Copy Link Print Information

Insulin Receptor Beta Antibody (YA341)

Customer Review

Based on 1 Customer Validation

Insulin Receptor Beta Antibody (YA341) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Insulin Receptor Beta.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, ICC/IF

  • Reactivity :

    Human, Rat

  • Formulation:

    Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Conjugation:
    Non-conjugated
ALL WB ICC
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Insulin Receptor Beta Antibody (YA341) Product Image
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Service
Data Download
Related Products:
Top Publications Citing

Use of MCE Products

Applications

Application
WB Info
WB: Western Blot
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
Dilution Ratio 1:500-1:2000 1:100-1:500

Product Details

Description

Insulin Receptor Beta Antibody (YA341) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Insulin Receptor Beta.

  • Host Rabbit
  • Clonality Recombinant, Monoclonal
  • Species Reactivity
    Human, Rat
  • Observed Molecular Weight
    Observed band size: 95 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 156 kDa
Species Reactivity Database
Immunogen

Synthetic peptide corresponding to Human Insulin Receptor.AA range:930-970.

Sensitivity

Endogenous

Purification

Protein A affinity purified.

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

RRID

AB_3102338

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    Western blot analysis of extracts from HCT116 (lane 2(20μg)，HepG2 (lane 3(20μg) and MDA-MB231 (lane 4(20μg) using Insulin Receptor Beta (HY-P80192) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192)at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

Background

  • Function

    Insulin Receptor Beta receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis[1][2].

  • Subcellular Localization

    Cell membrane; Single-pass type I membrane protein; Late endosome; Lysosome

  • Expression


    Tissue_specificity:Both the long and short subtypes are primarily expressed in target tissues involved in insulin metabolism, including the liver, adipose tissue, and skeletal muscle, but are also expressed in peripheral nerves, kidneys, alveoli, pancreatic acini, placental vascular endothelial cells, fibroblasts, monocytes, granulocytes, erythrocytes, and skin. The short subtype is preferentially expressed in fetal cells (such as fetal fibroblasts) , muscle, liver, and kidneys. A heterozygous receptor for IGF1R is present in muscle, heart, kidneys, adipose tissue, skeletal muscle, liver cancer, fibroblasts, spleen, and placenta (at the protein level) . It is overexpressed in various tumors, including breast cancer, colon cancer, lung cancer, ovarian cancer, and thyroid cancer.

  • Subunit

    Tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain.

  • SwissProt ID

    P06213

  • Gene ID
    3643 [NCBI]
  • Research Field

    Signal Transduction

Insulin Receptor Beta Antibody (YA341) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00

Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated CTLL-2 mouse cytotoxic T cells. The ED50 this effect is 0.8023 μg/ml, corresponding to a specific activity is 1246.42 units/mg.

Assay Types
  • 1/16

    MedchemExpress Validation
     Western blot analysis of extracts from HCT116 (lane 2(20μg)，HepG2 (lane 3(20μg) and MDA-MB231 (lane 4(20μg) using Insulin Receptor Beta (HY-P80192) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

  • 1/16

    MedchemExpress Validation
     Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192)at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • 1/16

    MedchemExpress Validation
     Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • Insulin Receptor Beta Antibody (YA341) Product Image
    1/16
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Insulin Receptor Beta Antibody (YA341) Product Image
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    1/1
    MedchemExpress Validation
     Western blot analysis of extracts from HCT116 (lane 2(20μg)，HepG2 (lane 3(20μg) and MDA-MB231 (lane 4(20μg) using Insulin Receptor Beta (HY-P80192) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    1/1
    MedchemExpress Validation
     Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192)at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
    1/1
    MedchemExpress Validation
     Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Experimental Validation Results for Insulin Receptor Beta Antibody (YA341)
  • Insulin Receptor Beta Antibody (YA341) Product Image
    MedchemExpress Validation

    Western blot analysis of extracts from HCT116 (lane 2(20μg)，HepG2 (lane 3(20μg) and MDA-MB231 (lane 4(20μg) using Insulin Receptor Beta (HY-P80192) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

  • Insulin Receptor Beta Antibody (YA341) Product Image
    MedchemExpress Validation

    Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192)at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • Insulin Receptor Beta Antibody (YA341) Product Image
    MedchemExpress Validation

    Immunocytochemistry analysis of HepG2 cells labeling Insulin Receptor Beta with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Insulin Receptor Beta Antibody (HY-P80192) at 1/250 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L（HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • Insulin Receptor Beta Antibody (YA341) Product Image WB
  • Insulin Receptor Beta Antibody (YA341) Product Image ICC
  • Insulin Receptor Beta Antibody (YA341) Product Image ICC